Targeting Neuroinflammation and Apoptosis: Cardamonin’s Cognitive Benefits in Alzheimer’s 5XFAD Mice
Neurochemical Research · 2025-02 · 50 (1)
DOI: 10.1007/s11064-024-04308-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemical Research, online erschienen am 14.12.2024. Verfasst von Shukur Wasman Smail. Beteiligte Einrichtung: Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq. shukur.smail@su.edu.krd. Hauptthemen laut MEDLINE: Alzheimer Disease, Mice, Transgenic, Apoptosis, Chalcones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
This study aimed to evaluate the cognitive-enhancing and neuroprotective effects of cardamonin in the 5XFAD transgenic mouse model of Alzheimer's disease (AD). We treated six-month-old female 5XFAD mice with cardamonin at 5 mg/kg, 10 mg/kg, and 20 mg/kg. Cognitive function was assessed using the Morris Water Maze (MWM) and Novel Object Recognition (NOR) tests. ELISA, western blot, and PCR analyses evaluated amyloid-beta (Aβ) levels, neuroinflammation markers, and apoptosis-related factor expression. All animals survived without toxicity. Cardamonin treatment significantly improved spatial learning and memory retention in MWM and NOR tests, with the 20 mg/kg dose showing the most pronounced effects. Additionally, cardamonin reduced soluble and insoluble Aβ levels in the frontal cortex and hippocampus. The treatment also significantly decreased neuroinflammatory markers, with IL-1β, IL-6, and TNF-α levels dropping substantially at higher doses. Cardamom treatment also normalizes cleaved caspase 3, GFAP, Iba-1, PSD-95, and synaptophysin, which aids in restoring synaptic integrity. Furthermore, cardamonin led to a marked reduction in apoptosis-related gene expression, indicating its potential to mitigate neurodegeneration. Cardamonin demonstrates significant cognitive-enhancing and neuroprotective properties in the 5XFAD mouse model, suggesting its potential as a therapeutic agent for AD. These findings support further investigation into cardamonin's mechanisms and applicability in treating neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq. shukur.smail@su.edu.krd.
- College of Pharmacy, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq. shukur.smail@su.edu.krd.
Zitieren
APA
Smail, S. W. (2025). Targeting Neuroinflammation and Apoptosis: Cardamonin’s Cognitive Benefits in Alzheimer’s 5XFAD Mice. Neurochemical Research, 50(1). https://doi.org/10.1007/s11064-024-04308-4
Vancouver
Smail SW. Targeting Neuroinflammation and Apoptosis: Cardamonin’s Cognitive Benefits in Alzheimer’s 5XFAD Mice. Neurochemical Research. 2025;50(1). doi:10.1007/s11064-024-04308-4
BibTeX
@article{Smail2025,
author = {Smail, Shukur Wasman},
title = {Targeting Neuroinflammation and Apoptosis: Cardamonin’s Cognitive Benefits in Alzheimer’s 5XFAD Mice},
journal = {Neurochemical Research},
year = {2025},
volume = {50},
number = {1},
doi = {10.1007/s11064-024-04308-4}
}
EUVIMED